This symposium will convene leaders from pharma, biotechnology, and academia to explore the potential of AI to accelerate the pharmaceutical lifecycle and deliver tomorrow’s medicines.

The afternoon program features conversations with leaders at the forefront of this transformation, including Chris Boerner, Board Chair and Chief Executive Officer of Bristol Myers Squibb; Kimberly Powell, Vice President of Healthcare at NVIDIA; and Aviv Regev, Head of Genentech Research and Early Development at Genentech.